Oppenheimer Maintains Outperform on Medtronic, Raises Price Target to $147
Oppenheimer analyst Steven Lichtman maintains Medtronic (NYSE:MDT) with a Outperform and raises the price target from $134 to $147.
Titan Medical Stock Jumps After Medtronic’s $10M Second Milestone Payment
Titan Medical Inc (NASDAQ:TMDI) has received $10 million under the second technical milestone under the development and license agreement with Medtronic plc (NYSE:MDT).…
Earnings Scheduled For May 27, 2021
Companies Reporting Before The Bell
• Royal Bank of Canada (NYSE:RY) is likely to report quarterly earnings at $2.48 per share on revenue of $11.77 billion.
The Power and Precision of BioSig’s PURE EP™ System in the Electrophysiology (EP) Market
Arrhythmia, a condition that causes the heart to beat with an irregular or abnormal rhythm, is the fourth leading disease in the United States. Untreated or undiagnosed, arrhythmias can increase the risk of severe health complications—including stroke or even death.
The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation
Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts.
Piper Sandler Maintains Overweight on Medtronic, Raises Price Target to $135
Piper Sandler maintains Medtronic (NYSE:MDT) with a Overweight and raises the price target from $125 to $135.
Stocks That Hit 52-Week Highs On Wednesday
During the morning session on Wednesday, 398 stocks hit new 52-week highs. Interesting Highlights: Alphabet (NASDAQ:GOOGL) was the largest company…